Does TOFACITINIB Cause Breast cancer? 318 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 318 reports of Breast cancer have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.2% of all adverse event reports for TOFACITINIB.
318
Reports of Breast cancer with TOFACITINIB
0.2%
of all TOFACITINIB reports
18
Deaths
58
Hospitalizations
How Dangerous Is Breast cancer From TOFACITINIB?
Of the 318 reports, 18 (5.7%) resulted in death, 58 (18.2%) required hospitalization, and 20 (6.3%) were considered life-threatening.
Is Breast cancer Listed in the Official Label?
Yes, Breast cancer is listed as a known adverse reaction in the official FDA drug label for TOFACITINIB.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Breast cancer?
RANITIDINE (45,666)
LETROZOLE (1,393)
ETANERCEPT (1,303)
METHOTREXATE (936)
ADALIMUMAB (894)
INFLIXIMAB (789)
RIBOCICLIB (788)
FULVESTRANT (684)
DENOSUMAB (671)
ABATACEPT (617)
Which TOFACITINIB Alternatives Have Lower Breast cancer Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN